679 related articles for article (PubMed ID: 32086125)
1. Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infections.
LLopis B; Funck-Brentano C; Tissot N; Bleibtreu A; Jaureguiberry S; Fourniols E; Aubry A; Zahr N
J Pharm Biomed Anal; 2020 May; 183():113137. PubMed ID: 32086125
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS/MS method.
Paal M; Zoller M; Schuster C; Vogeser M; Schütze G
J Pharm Biomed Anal; 2018 Apr; 152():102-110. PubMed ID: 29414000
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
Hösl J; Gessner A; El-Najjar N
J Pharm Biomed Anal; 2018 Aug; 157():92-99. PubMed ID: 29777985
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of isoniazid, rifampicin, levofloxacin in mouse tissues and plasma by high performance liquid chromatography-tandem mass spectrometry.
Fang PF; Cai HL; Li HD; Zhu RH; Tan QY; Gao W; Xu P; Liu YP; Zhang WY; Chen YC; Zhang F
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(24):2286-91. PubMed ID: 20663720
[TBL] [Abstract][Full Text] [Related]
5. Robust HPLC-MS/MS method for levofloxacin and ciprofloxacin determination in human prostate tissue.
Szerkus O; Jacyna J; Gibas A; Sieczkowski M; Siluk D; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2017 Jan; 132():173-183. PubMed ID: 27744176
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin in microvolumes of human plasma using high-performance liquid chromatography with ultraviolet detection.
Zheng Y; Wang Z; Lui G; Hirt D; Treluyer JM; Benaboud S; Aboura R; Gana I
Biomed Chromatogr; 2019 May; 33(5):e4506. PubMed ID: 30743308
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Kai M; Tanaka R; Suzuki Y; Goto K; Ohchi Y; Yasuda N; Tatsuta R; Kitano T; Itoh H
Clin Biochem; 2021 Apr; 90():40-49. PubMed ID: 33539809
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122397. PubMed ID: 33091676
[TBL] [Abstract][Full Text] [Related]
9. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.
Huynh HH; Pressiat C; Sauvageon H; Madelaine I; Maslanka P; Lebbé C; Thieblemont C; Goldwirt L; Mourah S
Ther Drug Monit; 2017 Feb; 39(1):43-54. PubMed ID: 27861317
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.
Lee SJ; Desta KT; Eum SY; Dartois V; Cho SN; Bae DW; Shin SC
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():138-43. PubMed ID: 26730550
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers.
Helmy SA
Ther Drug Monit; 2013 Dec; 35(6):770-7. PubMed ID: 24061442
[TBL] [Abstract][Full Text] [Related]
14. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an ultra-high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of direct oral anticoagulants in human plasma.
Zhang YF; Liu XQ; Wang Y; Xu X; Zhong MK; Zhang P; Ma CL
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122952. PubMed ID: 34598085
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Measurement of 11 Antibiotics for Use in the Intensive Care Unit by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Woksepp H; Karlsson L; Ärlemalm A; Hällgren A; Schön T; Carlsson B
Ther Drug Monit; 2022 Apr; 44(2):308-318. PubMed ID: 34224537
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Acetaminophen and Its Metabolites in Plasma Using UPLC-MS: Doors Open to Therapeutic Drug Monitoring in Special Patient Populations.
Flint RB; Mian P; van der Nagel B; Slijkhuis N; Koch BC
Ther Drug Monit; 2017 Apr; 39(2):164-171. PubMed ID: 28169862
[TBL] [Abstract][Full Text] [Related]
18. Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring.
Shibata M; Hashi S; Nakanishi H; Masuda S; Katsura T; Yano I
Biomed Chromatogr; 2012 Dec; 26(12):1519-28. PubMed ID: 22383262
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Pressiat C; Huynh HH; Plé A; Sauvageon H; Madelaine I; Chougnet C; Le Maignan C; Mourah S; Goldwirt L
Ther Drug Monit; 2018 Jun; 40(3):337-343. PubMed ID: 29474275
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS method for the simultaneous determination of PA-824, moxifloxacin and pyrazinamide in rat plasma and its application to pharmacokinetic study.
Wang L; Xu Y; Liang L; Diao C; Liu X; Zhang J; Zhang S
J Pharm Biomed Anal; 2014 Aug; 97():1-8. PubMed ID: 24798753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
